Notice Number: NOT-EB-17-002

Key Dates
Release Date: May 24, 2017

Issued by
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
National Institute on Aging (NIA)

Purpose

The National Institute of Biomedical Imaging and Bioengineering (NIBIB), in partnership with the National Institute on Aging (NIA), announces an opportunity for NIBIB-supported investigators to request administrative supplements to develop new tools, technologies and approaches for the prevention, diagnosis, treatment and understanding of Alzheimer's Disease and Alzheimer's-disease-related dementias (AD/ADRD). These supplements will be funded by NIA as part of the NIA strategic plan to support the development of innovative strategies to prevent, diagnose and treat AD/ADRD.

Administrative supplement requests should be submitted to PA-16-287, Administrative Supplements to Existing NIH Grants and Cooperative Agreements https://grants.nih.gov/grants/guide/pa-files/PA-16-287.html. The requested supplemental budget cannot exceed $100,000 in direct costs for up to 12 months. The project and budget periods of the supplement request must be within the currently approved project period for the existing parent award.

Supplements will be considered for active NIBIB-funded projects that may have important application in AD/ADRD. Administrative supplements may be awarded to meet increased costs that are within the scope of the approved award, but were unforeseen when the application was submitted. For the purposes of this Notice, "within scope" may include the addition of an AD/ADRD-relevant component to a project employing or developing a broadly applicable technology. Applicants are strongly encouraged to discuss the aims of the proposed work with the NIBIB program officer assigned to the parent grant to assess suitability for this funding opportunity.

Requests must be received by July 3, 2017.

Inquiries

Please direct all inquiries to:

Randy King, PhD
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
Telephone: 301-451-0707
Email: [email protected]